A5080696755- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Mechanisms and Therapy
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Hepatitis C virus research
- Renal cell carcinoma treatment
- Medical Imaging Techniques and Applications
- Lung Cancer Diagnosis and Treatment
Third Affiliated Hospital of Sun Yat-sen University
2021-2024
Sun Yat-sen University
2021-2024
Fifth Affiliated Hospital of Sun Yat-sen University
2021
Purpose: This study aimed to assess the effectiveness and safety of combining hepatic arterial infusion chemotherapy (HAIC) with lenvatinib (LEN) PD-1 inhibitors in treating arterioportal shunt (APS) hepatocellular carcinoma (HCC) patients portal vein tumor thrombus (PVTT). Patients Methods: Conducted retrospectively, enrolled 54 HCC APS PVTT treated HAIC, LEN, at our center between January 2021 October 2023. improvement, recanalization, response, response rate, overall survival (OS),...
<title>Abstract</title> <bold>Background:</bold> To compare the treatment efficacy and safety of transarterial chemoembolization (TACE) combined with lenvatinib versus TACE alone in patients intermediate-stage hepatocellular carcinoma (HCC) beyond up-to-seven criteria. <bold>Methods:</bold> A total 107 newly diagnosed HCC Barcelona Clinic Liver Cancer stage B criteria were included this retrospective cohort study. These divided into two groups: TACE-Lenv group group. Propensity score...
To further evaluate the efficacy and safety of computed tomography (CT)-guided iodine 125 (125I) brachytherapy to treat locally advanced non-small cell lung cancer (NSCLC) after progression concurrent radiochemotherapy (CCRT).This study obtained written consent from all patients was approved by our institution. From January 2006 June 2018, 210 NSCLC (progression first-line CCRT) were retrospectively recruited then divided into two groups. A total 116 given CT-guided 125I second-line...